Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Profit & Loss
Concord Biotech Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value(
)
543960
INE338H01029
152.0404927
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
CONCORDBIO
63.29
20803.46
EPS(TTM)
Face Value(
)
Div & Yield %:
31.42
1
0.44
Particulars(INCOME)
Mar 2024
(
Cr)
Mar 2023
(
Cr)
Mar 2022
(
Cr)
Mar 2021
(
Cr)
Mar 2020
(
Cr)
Mar 2019
(
Cr)
Sales Turnover
1016.94
853.17
712.93
616.94
512.33
436.01
Excise Duty
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
1016.94
853.17
712.93
616.94
512.33
436.01
Other Income
33.78
35.31
23.42
13.81
31.37
17.44
Stock Adjustments
12.08
15.63
23.98
39.05
4.85
1.16
Total Income
1062.80
904.11
760.33
669.80
548.55
454.61
EXPENDITURE :
Raw Materials
241.28
195.84
187.99
150.61
134.79
109.17
Power & Fuel Cost
104.97
97.65
71.64
39.86
37.30
36.29
Employee Cost
123.05
110.28
95.69
69.47
62.24
48.08
Other Manufacturing Expenses
28.00
24.93
17.10
12.99
30.93
12.53
Selling & Administrative Expenses
91.08
82.93
67.90
44.87
31.74
35.72
Miscellaneous Expenses
8.46
13.20
22.66
10.26
15.65
14.90
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
596.83
524.84
462.99
328.05
312.65
256.69
Operating Profit
465.97
379.27
297.34
341.74
235.91
197.92
Interest
3.18
5.18
6.13
1.05
1.17
0.69
Gross Profit
462.79
374.09
291.21
340.69
234.74
197.23
Depreciation
53.59
54.03
50.05
27.52
21.25
19.31
Profit Before Tax
409.20
320.06
241.16
313.17
213.49
177.92
Tax
99.83
79.53
58.49
75.72
54.53
55.62
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
4.63
2.40
4.10
2.11
-10.00
3.91
Reported Net Profit
304.73
238.13
178.57
235.33
168.96
118.39
Extraordinary Items
10.48
2.70
3.86
5.24
17.47
1.53
Adjusted Net Profit
294.25
235.43
174.71
230.09
151.49
116.86
Adjustment below Net Profit
-0.01
0.26
-0.56
-0.04
-0.84
0.14
P & L Balance brought forward
1170.33
985.51
878.02
648.43
560.85
472.71
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
71.45
53.56
70.52
5.71
80.55
30.38
P & L Balance carried down
1403.60
1170.33
985.51
878.02
648.43
560.85
Dividend
0.00
0.00
0.00
0.00
0.00
25.20
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
875.00
683.00
51.20
0.00
392.50
264.50
Dividend Per Share(Rs)
8.75
6.83
5.12
0.00
39.25
26.45
Earnings Per Share-Unit Curr
29.13
22.76
187.76
247.44
177.66
124.48
Earnings Per Share(Adj)-Unit Curr
29.13
22.76
187.76
247.44
177.66
124.48
Book Value-Unit Curr
145.80
123.50
1164.13
1051.11
809.71
717.62
Book Value(Adj)-Unit Curr
145.80
123.50
1164.13
1051.11
809.71
717.62